Despite considerable regulatory interventions to mitigate air pollution, fine particulate matter (PM2.5) remains a critical health threat across China. Carbon neutrality strategies, though primarily aimed at mitigating climate change, may also yield substantial co-benefits for air quality and public health. However, th...
Jian-Hui Guo, Lin Lin, P. Koutrakis et al.· The Innovation Medicine· 0 citations
Asthma mortality in China has declined substantially, but the nonfatal burden continues to rise, driven by increasing prevalence and metabolic risk factors.
Zhuo Wang, Yi-Ding Zhuang, Jin-Lei Qi et al.· Chinese Medical Journal· 0 citations
The disease burden of MDR-TB in China and its provinces from 1990 to 2023 is assessed, using data from the Global Burden of Disease Study (GBD) 2023 database to project the disease burden trends from 2024 to 2050.
Shunxiang Zhang, Jin-Lei Qi, Jinxin Zheng et al.· Journal of Infection· 1 citation
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.